The Complexity of ADHD: Diagnosis and Treatment of the Adult Patient With Comorbidities
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is an impairing but usually treatable condition. Popular culture propagates the myth that ADHD recedes with age; this is not the case. Although it is common, <20% of adults with ADHD are diagnosed or treated. Adults with ADHD show significant comorbidities with depressive disorders, anxiety disorders, substance use, oppositional defiant disorder, personality disorders, sleep problems, and learning disabilities. However, symptoms that result from ADHD, such as mood symptoms or lability, are often mistaken for comorbid disorders. Comorbidity with ADHD impacts treatment compliance, treatment response, and patient insight. Insufficient data on the interaction between ADHD and comorbidities impedes proper diagnosis and treatment. Better clinical tools for assessing these conditions are needed. Food and Drug Administration-approved pharmacologic treatments for adult ADHD include stimulants, dexmethylphenidate, and the nonstimulant atomoxetine. Effect sizes of approved medicines at approved doses are half those seen in children. Adults may also need longer duration of medication effects than children. Short-acting stimulants are likely to result in poorer adherence and have a higher risk for diversion or abuse. Risk of abuse is a major concern; stimulant treatments are controlled substances, and children with ADHD show increased risk of substance abuse. Psychosocial interventions may be beneficial in treating both ADHD and comorbidities. In this expert roundtable supplement, Margaret Weiss, MD, PhD, presents a comprehensive overview of complications surrounding differential diagnosis in adults with ADHD. Next, Mark A. Stein, PhD, reviews evaluation, comorbidity, and development of a treatment plan in this population. Finally, Jeffrey H. Newcorn, MD, provides a discussion on the pharmacologic options available for adults with ADHD, considering dosages specific to adults and common comorbidities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of psychiatric comorbidities can complicate ADHD management,9,10 which may result in an increased burden on patients, clinicians, and the health care system at large.”
From Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder (2024) · cites this paper as [9]
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1792 · Cited by 950
BIEDERMAN, J., MONUTEAUX, M. C., MICK, E., SPENCER, T., WILENS, T. E., SILVA, J. M., SNYDER, L. E., & FARAONE, S. V. (2006) · Psychological Medicine · doi:10.1017/s0033291705006410 · Cited by 850
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790
Attention-Deficit/Hyperactivity Disorder: Diagnosis, Lifespan, Comorbidities, and Neurobiology
Spencer, T. J., Biederman, J., & Mick, E. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm005 · Cited by 634
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms
Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.001 · Cited by 519
Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., Atkins, M., McBurnett, K., Bukstein, O., August, G., et al. (2001) · Pediatrics · doi:10.1542/peds.108.4.883 · Cited by 502
Hallowell, E. M., & Ratey, J. J. (1994) · Medical Entomology and Zoology · Cited by 441
Long-Term Outcome of Hyperactive Children: A Review
KLEIN, R. G., & MANNUZZA, S. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199105000-00005 · Cited by 406
Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385
Research works printed but not linked: 8
- Geller, J Am Acad Child Adolesc Psychiatry
- First, 1997, Williams JBW. SCID-I, Clinician Version
- Barkley, 1998, A Handbook for Diagnosis and Treatment, 594
- Adler, 2006, Scattered Minds
- 2006, Canadian Attention Deficit Disorder Resource Alliance. Canadian Practice Guidelines for ADHD
- Faraone, 2005, Adult ADHD NOS: Is it a valid diosrder?
- Gadow, 2004, Manual for the Adult Self Report Inventory and Adult Symptom Inventory
- Jasinski, 2006, Abuse liability of intravenous L-lysine-damphetamine (LDX)
Cited by
Ginsberg, Y., Quintero, J., Anand, E., Casillas, M., & Upadhyaya, H. P. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01600 · Cited by 274
Adult ADHD and its comorbidities, with a focus on bipolar disorder
Klassen, L. J., Katzman, M. A., & Chokka, P. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.036 · Cited by 205
Distinguishing comorbidity and successful management of adult ADHD
Kooij, J. J. S., Huss, M., Asherson, P., Akehurst, R., Beusterien, K., French, A., Sasané, R., & Hodgkins, P. (2012) · Journal of Attention Disorders · doi:10.1177/1087054711435361 · Cited by 172
Adult ADHD: Underdiagnosis of a Treatable Condition
Rivas-Vazquez, R. A., Diaz, S. G., Visser, M. M., & Rivas-Vazquez, A. A. (2023) · Journal of Health Service Psychology · doi:10.1007/s42843-023-00077-w · Cited by 98
Sarris, J., Kean, J., Schweitzer, I., & Lake, J. (2011) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2011.06.007 · Cited by 86
Metadata
- Authors
- Newcorn, J. H., Weiss, M., & Stein, M. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2007
- Volume
- 12
- Issue
- S12
- Pages
- 1-16
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W2103982384
- Semantic Scholar
- 99fb0300a554b27fc1acdf3b5513ec109ff4f061
- Cited by
- 66
- References
- 41
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 7 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 4
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Spectrums (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Keywords
- adult ADHD, ADHD comorbidity, differential diagnosis, stimulant medication, atomoxetine, dexmethylphenidate, medication adherence, substance use disorders, depressive disorders, anxiety disorders, oppositional defiant disorder, personality disorders, sleep disorders, learning disabilities, psychosocial interventions
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Bipolar Disorder, Cognition Disorders, Diagnosis, Differential, Humans, Patient Education as Topic, Personality Disorders, Severity of Illness Index, Comorbidity, Dysthymic Disorder, Attention Deficit and Disruptive Behavior Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Complexity of ADHD: Diagnosis and Treatment of the Adult Patient With Comorbidities. https://app.cochat.ai/papers/10.1017/s1092852900026158
- The paper
- Newcorn, J. H., Weiss, M., & Stein, M. A. (2007). The Complexity of ADHD: Diagnosis and Treatment of the Adult Patient With Comorbidities. CNS Spectrums. https://doi.org/10.1017/s1092852900026158
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.